Boothbay Fund Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1925 |
|
|
2023
Q3 | – | Sell |
-941,755
| Closed | -$10.4M | – | 1973 |
|
|
2023
Q2 | $10.4M | Buy |
941,755
+930,155
| +8,019% | +$10.3M | 0.23% | 47 |
|
|
2023
Q1 | $156K | Hold |
11,600
| – | – | ﹤0.01% | 1571 |
|
|
2022
Q4 | $143K | Hold |
11,600
| – | – | ﹤0.01% | 1465 |
|
|
2022
Q3 | $162K | Sell |
11,600
-4,779
| -29% | -$66.7K | ﹤0.01% | 1639 |
|
|
2022
Q2 | $226K | Buy |
+16,379
| New | +$226K | 0.01% | 1422 |
|
|
2022
Q1 | – | Sell |
-20,294
| Closed | -$331K | – | 2285 |
|
|
2021
Q4 | $331K | Buy |
+20,294
| New | +$331K | 0.01% | 1061 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 2042 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 1994 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 1644 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1178 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1033 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 1035 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 958 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 862 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 850 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 834 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 867 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 869 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 824 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 574 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 538 |
|